World Drug Discovery Technologies Outlook
World Drug Discovery Technologies Outlook
RELEASE DATE
20-May-2004
20-May-2004
REGION
Global
Global
Research Code: A815-01-00-00-00
SKU: HC00974-GL-MR_04842
$10,000.00
In stock
SKU
HC00974-GL-MR_04842
Description
The World Drug Discovery Technologies market is a dynamic marketplace with substantial opportunity. This study focuses on the market dynamics of 2003, by looking at the four major contributors to this market: top 15 pharmaceutical companies, biotechnology companies, top 5 agribiotech companies, and the NIH budget. The study also provides detailed analysis of the top competitors in the research products market, as well as those who have been affected by changing market dynamics.
Table of Contents
Introduction
- Introduction
- Disclaimer
- Certification
- Research Scope and Methodology
Market Overview
- Outline I
- Market Segmentation
- Drug Discovery Process
- Clinical Trials Process
- Market Challenges
- Technology and Product Trends
- Challenges & Strategies
Overview of Drug Discovery Technologies Market
- Outline II
- Who are the Top 15 Vendors?
- Market Positioning
- Where did 2003 Growth Come From?
- Effects of Global Economies
- Consumers of Research Products
- Future Market Growth
- Key Factors Facing Consumers
- Market Revenue Analysis
- Top Down and Bottom Up Analysis
- Research Products Market Forecast
- Research Products Market Forecast by Segment
Top 15 Pharmaceutical Spending
- Outline III
- Market Share of Top 15 Pharmaceutical Companies
- Top 15 Pharma Companies - Revenue Forecast
- Top 15 Pharma Companies - R&D Spending Forecast
- Pre-Clinical Spending - Top 15 Pharmaceutical Companies
Biotechnology Spending
- Outline IV
- Drug Discovery Biotech Market Share
- Drug Discovery R&D Expenditure
- Drug Discovery Biotech - Revenue Forecast
- Drug Discovery Biotech - R&D Spending Forecast
- Pre-Clinical Spending - Biotech
Academic and Government Spending
- Outline V
- NIH Budget Historical
- Academic and Government (NIH) R&D Spending
- Shifting Focus for Government-Funded Research I
- Shifting Focus for Government-Funded Research II
- Shifting Focus for Government-Funded Research III
Top 5 Agribiotech Spending
- Outline VI
- Top 5 Agribiotech Market Share
- Top 5 Agribiotech - Revenue Forecast
- Top 5 Agribiotech - R&D Spending Forecast
- R&D Spending - Top 5 Agribiotech
Summary of R&D Spending
- Outline VII
- R&D Budget for Research Products
- Consumers of Research Products
- Consumer Priorities
- Key Market Engineering Measurements
Competitive Landscape
- Outline VIII
- VWR International
- Fisher Scientific I
- Fisher Scientific II
- Fisher Scientific III
- Applied Biosystems I
- Applied Biosystems II
- Sigma-Aldrich I
- Sigma-Aldrich II
- Thermo Electron I
- Thermo Electron II
- Agilent Technologies I
- Agilent Technologies II
- Agilent Technologies III
- Amersham Biosciences
- PerkinElmer I
- PerkinElmer II
- Waters Corporation I
- Waters Corporation II
- Millipore I
- Millipore II
- Invitrogen I
- Invitrogen II
- Invitrogen III
- BD Biosciences I
- BD Biosciences II
- BD Biosciences III
- Beckman Coulter I
- Beckman Coulter II
- Bio-Rad I
- Bio-Rad II
Companies Affected by Changing Market Dynamics
- Outline IX
- Ciphergen I
- Ciphergen II
- Illumina I
- Illumina II
- Luminex I
- Luminex II
- Incyte
- Celera
- Pharmacopeia
Decision Support Data
- Outline X
- Major Sequencing Centers
- Biological and Medical Scientists
- Biotechnology Companies I
- Biotechnology Companies II
- Macro Economic Analysis
- Already known to 2010 and beyond
Frost & Sullivan Awards
- Outline XI
- Introduction to Frost & Sullivan Awards
- Product & Service Leadership
- Growth Strategy
- Technology Leadership
- Business Development Strategy
Frost & Sullivan Research Capabilities
- Outline XII
- Healthcare Team
- Our Capabilities
- Key Advantages
- Our Consulting Clients
- Frost & Sullivan Growth Consulting
- Growth Consulting Process
- Growth Consulting Deliverables
- Growth Partnership Service
- Growth Partnership Services Platform
Related Research
Popular Topics
The World Drug Discovery Technologies market is a dynamic marketplace with substantial opportunity. This study focuses on the market dynamics of 2003, by looking at the four major contributors to this market: top 15 pharmaceutical companies, biotechnology companies, top 5 agribiotech companies, and the NIH budget. The study also provides detailed analysis of the top competitors in the research products market, as well as those who have been affected by changing market dynamics.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | A815-01-00-00-00 |
Is Prebook | No |